Verdicts genuinely change. Free email alert the moment ECHSX's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Eaton Vance Worldwide Health Sciences Fund · Eaton Vance Growth Trust
42 holdings
NON-COMPLIANT 12.75% of portfolio weight is in non-compliant holdings, over the 5% threshold.
42 holdings, 36 matched (97% of weight). Portfolio as of 2026-05-31, filed 2026-07-27. Source: SEC Form N-PORT.
0.72% of this portfolio’s income is non-permissible — weighted across holdings, computed over 82% of portfolio weight (31 of 42 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
84.0% compliant 0.0% questionable 12.8% non-compliant 3.0% unscreened
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| LLY Eli Lilly & Co | COMPLIANT | 12.47% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| ABBV AbbVie Inc | COMPLIANT | 6.46% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| JNJ Johnson & Johnson | COMPLIANT | 6.45% | AAOIFI7.6% Usmani24.4% Dow Jones Islamic10.9% S&P Shariah11.7% MSCI Islamic24.4% MSCI Islamic M-Series11.7% FTSE Shariah24.4% |
| AZN AstraZeneca PLC | COMPLIANT | 6.24% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| UNH UnitedHealth Group Inc | NON_COMPLIANT | 5.49% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| RO.SW Roche Holding AG | COMPLIANT | 5.44% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| MRK Merck & Co Inc | COMPLIANT | 5.08% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| BMY Bristol-Myers Squibb Co | NON_COMPLIANT | 4.25% | AAOIFI37.3% Usmani51.1% Dow Jones Islamic42.2% S&P Shariah44.8% MSCI Islamic51.1% MSCI Islamic M-Series44.8% FTSE Shariah48.9% |
| VRTX Vertex Pharmaceuticals Inc | COMPLIANT | 3.38% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| GILD Gilead Sciences Inc | COMPLIANT | 3.34% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| SNY Sanofi SA | COMPLIANT | 2.95% | AAOIFI20.8% Usmani14.7% Dow Jones Islamic38.1% S&P Shariah38.6% MSCI Islamic14.7% MSCI Islamic M-Series38.6% FTSE Shariah14.7% |
| TMO Thermo Fisher Scientific Inc | COMPLIANT | 2.79% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| ISRG Intuitive Surgical Inc | COMPLIANT | 2.72% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| SYK Stryker Corp | COMPLIANT | 2.21% | AAOIFI14.6% Usmani32.2% Dow Jones Islamic11.3% S&P Shariah11.8% MSCI Islamic32.2% MSCI Islamic M-Series11.8% FTSE Shariah31.2% |
| BSX Boston Scientific Corp | COMPLIANT | 2.18% | AAOIFI19.4% Usmani27.9% Dow Jones Islamic10.0% S&P Shariah10.9% MSCI Islamic27.9% MSCI Islamic M-Series10.9% FTSE Shariah27.9% |
| MDT Medtronic PLC | COMPLIANT | 1.80% | AAOIFI24.4% Usmani31.5% Dow Jones Islamic26.4% S&P Shariah27.4% MSCI Islamic31.4% MSCI Islamic M-Series27.4% FTSE Shariah30.2% |
| LONN.SW Lonza Group AG | COMPLIANT | 1.77% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| NOVO-B.CO Novo Nordisk A/S | COMPLIANT | 1.71% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| ABT Abbott Laboratories | COMPLIANT | 1.65% | AAOIFI19.2% Usmani31.9% Dow Jones Islamic17.6% S&P Shariah18.3% MSCI Islamic31.9% MSCI Islamic M-Series18.3% FTSE Shariah30.8% |
| NVS Novartis AG | COMPLIANT | 1.65% | AAOIFI12.5% Usmani25.9% Dow Jones Islamic11.8% S&P Shariah12.6% MSCI Islamic25.9% MSCI Islamic M-Series12.6% FTSE Shariah25.9% |
| ARGX Argenx SE | COMPLIANT | 1.61% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| RPRX Royalty Pharma PLC | NON_COMPLIANT | 1.58% | AAOIFI24.4% Usmani45.2% Dow Jones Islamic60.3% S&P Shariah67.3% MSCI Islamic45.2% MSCI Islamic M-Series67.3% FTSE Shariah45.2% |
| NBIX Neurocrine Biosciences Inc | COMPLIANT | 1.41% | AAOIFI2.9% Usmani8.6% Dow Jones Islamic3.4% S&P Shariah3.5% MSCI Islamic8.6% MSCI Islamic M-Series3.5% FTSE Shariah0.0% |
| MTD Mettler-Toledo International Inc | COMPLIANT | 1.36% | AAOIFI7.8% Usmani57.5% Dow Jones Islamic8.0% S&P Shariah7.9% MSCI Islamic57.5% MSCI Islamic M-Series7.9% FTSE Shariah57.5% |
| STMN.SW Straumann Holding AG | COMPLIANT | 1.34% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| DGX Quest Diagnostics Inc | COMPLIANT | 1.30% | AAOIFI24.4% Usmani37.7% Dow Jones Islamic32.1% S&P Shariah35.4% MSCI Islamic37.7% MSCI Islamic M-Series35.4% FTSE Shariah33.3% |
| GMAB.CO Genmab A/S | COMPLIANT | 1.20% | AAOIFIpass Usmanifail Dow Jones Islamicfail S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| EW Edwards Lifesciences Corp | COMPLIANT | 1.17% | AAOIFI1.4% Usmani5.1% Dow Jones Islamic1.5% S&P Shariah1.5% MSCI Islamic5.1% MSCI Islamic M-Series1.5% FTSE Shariah4.3% |
| ZTS Zoetis Inc | NON_COMPLIANT | 1.12% | AAOIFI29.0% Usmani61.3% Dow Jones Islamic15.4% S&P Shariah14.0% MSCI Islamic61.3% MSCI Islamic M-Series14.0% FTSE Shariah60.0% |
| COO Cooper Cos Inc/The | COMPLIANT | 1.04% | AAOIFI23.0% Usmani20.1% Dow Jones Islamic16.7% S&P Shariah15.5% MSCI Islamic20.1% MSCI Islamic M-Series15.5% FTSE Shariah20.1% |
| CSL.AX CSL Ltd | COMPLIANT | 0.91% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| HTFL HeartFlow Inc | COMPLIANT | 0.90% | AAOIFI0.6% Usmani7.9% Dow Jones Islamicpass S&P Shariahpass MSCI Islamic7.9% MSCI Islamic M-Seriespass FTSE Shariah0.0% |
| DHR Danaher Corp | COMPLIANT | 0.89% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| Recordati Industria Chimica e Farmaceutica SpA | UNSCREENED | 0.73% | no in-house ratios for this holding |
| Xenon Pharmaceuticals Inc | UNSCREENED | 0.72% | no in-house ratios for this holding |
| Generate Biomedicines Inc | UNSCREENED | 0.54% | no in-house ratios for this holding |
| Apogee Therapeutics Inc | UNSCREENED | 0.36% | no in-house ratios for this holding |
| Newamsterdam Pharma Co NV | UNSCREENED | 0.36% | no in-house ratios for this holding |
| MS Morgan Stanley & Co. LLC | NON_COMPLIANT | 0.31% | AAOIFI115.6% Usmani23.4% Dow Jones Islamic161.6% S&P Shariah189.1% MSCI Islamic23.4% MSCI Islamic M-Series189.1% FTSE Shariah23.4% |
| CAI Caris Life Sciences Inc | COMPLIANT | 0.30% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| EL.PA EssilorLuxottica SA | COMPLIANT | 0.28% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| MBX Biosciences Inc | UNSCREENED | 0.25% | no in-house ratios for this holding |
The published standards disagree about this fund by 44 points of portfolio weight — 80.6% of it passes AAOIFI, 36.7% passes Usmani. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 80.6% ratios fail on 4.6% 14.5% not rated under AAOIFI
ratios pass on 36.7% ratios fail on 48.2% 14.8% not rated under Usmani
ratios pass on 73.3% ratios fail on 10.3% 16.2% not rated under Dow Jones Islamic
ratios pass on 73.2% ratios fail on 10.4% 16.2% not rated under S&P Shariah
ratios pass on 40.2% ratios fail on 46.4% 13.1% not rated under MSCI Islamic
ratios pass on 73.2% ratios fail on 10.4% 16.2% not rated under MSCI Islamic M-Series
ratios pass on 42.7% ratios fail on 40.5% 16.5% not rated under FTSE Shariah
36 of 42 listed holdings carry our own per-methodology verdicts (97% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 25 (69% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Eaton Vance Worldwide Health Sciences Fund (ECHSX) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A holding it cannot cover far enough is reported as unrated rather than counted as a pass.
| Holding | Weight | Verdict |
|---|---|---|
| LLYEli Lilly & Co | 12.47% | Compliant |
| ABBVAbbVie Inc | 6.46% | Compliant |
| JNJJohnson & Johnson | 6.45% | Compliant |
| AZNAstraZeneca PLC | 6.24% | Compliant |
| UNHUnitedHealth Group Inc | 5.49% | Non-compliant |
| RO.SWRoche Holding AG | 5.44% | Compliant |
| MRKMerck & Co Inc | 5.08% | Compliant |
| BMYBristol-Myers Squibb Co | 4.25% | Non-compliant |
| VRTXVertex Pharmaceuticals Inc | 3.38% | Compliant |
| GILDGilead Sciences Inc | 3.34% | Compliant |
Top 10 of 42 holdings, 58.6% of the fund by weight. Every holding is screened, not only these.
The positions keeping this fund short of 100% compliant by weight.
Verdict history for ECHSX. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
Tracked since 2026-09-07.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
This fund prices once a day, so its bars carry no intraday high or low — floor-trader pivots are not defined for it.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 58.30 | NEUTRAL |
| Stochastic %K (14) | 85.51 | SELL |
| CCI (20) | 116.96 | SELL |
| Williams %R (14) | -14.49 | SELL |
| MACD (12,26,9) | 0.06 | BUY |
| ROC (10) | 3.85 | BUY |
| Momentum (10) | 0.51 | BUY |
| EMA (10) | 13.58 | BUY |
| SMA (10) | 13.50 | BUY |
| EMA (20) | 13.51 | BUY |
| SMA (20) | 13.46 | BUY |
| EMA (30) | 13.50 | BUY |
| SMA (30) | 13.43 | BUY |
| EMA (50) | 13.46 | BUY |
| SMA (50) | 13.58 | BUY |
| EMA (100) | 13.31 | BUY |
| SMA (100) | 13.27 | BUY |
| EMA (200) | 13.16 | BUY |
| SMA (200) | 13.05 | BUY |
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
The questions worth asking about any verdict on this page, answered plainly.
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.